| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/18/2006 | EP1463799A4 Methods for the induction of professional and cytokine-producing regulatory cells |
| 01/18/2006 | EP1373547A4 Control of glycoforms in igg |
| 01/18/2006 | EP1278851B1 Humanised antibodies to the epidermal growth factor receptor |
| 01/18/2006 | EP1127068B1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 01/18/2006 | EP1018548B1 Cellular immunogenicity potentiating composition containing alpha-glycosylceramide |
| 01/18/2006 | EP0904101B1 Nucleic acids encoding gdp-fucose pyrophosphorylase |
| 01/18/2006 | EP0782630B1 Polycystic kidney disease gene |
| 01/18/2006 | CN1723391A Oligopeptides for promoting hair growth |
| 01/18/2006 | CN1723286A Method for the biotechnological production of citric acid by means of a genetically-modified yeast yarrowia lipolytica |
| 01/18/2006 | CN1723283A Method for manufacturing recombinant polyclonal proteins |
| 01/18/2006 | CN1723281A Mutated d-aminotransferase and method for producing optically active glutamic acid derivatives using the same |
| 01/18/2006 | CN1723278A Radio link protocol sync procedure |
| 01/18/2006 | CN1723277A Culture medium composition, culture method, and myoblasts obtained, and their uses |
| 01/18/2006 | CN1723038A Pharmaceutical composition for inducing an immune response in a human or animal |
| 01/18/2006 | CN1723037A Methods and compositions for promoting the maturation of monocytes |
| 01/18/2006 | CN1721536A Plant-disease-resistance related protein and genes encoding same and use thereof |
| 01/18/2006 | CN1721529A Trap vector and gene trapping method by using the same |
| 01/18/2006 | CN1721527A Polypeptides having branching enzyme activity and nucleic acids encoding same |
| 01/18/2006 | CN1721525A Method for inducing neural differentiation and composition |
| 01/18/2006 | CN1721444A Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 01/18/2006 | CN1721443A Human receptor proteins, related reagents and methods |
| 01/18/2006 | CN1721442A Proteins producing an altered immunogenic response and methods of making and using the same |
| 01/18/2006 | CN1721441A Novel hepatic factor of human embryo |
| 01/18/2006 | CN1721432A Peptide specifically associated with front surface antigen zone of large protein of human hepatitis B virus surface antigen and uses thereof |
| 01/18/2006 | CN1237170C Method of proliferating natural killer cells |
| 01/18/2006 | CN1237076C Polypeptide variants with altered effector function |
| 01/17/2006 | US6987218 transgenic seeds/plants; horticulture; improved herbicide/insect/disease resistance; improved fatty acid/carbohydrate metabolism |
| 01/17/2006 | US6987217 Hybrid maize 32B10 |
| 01/17/2006 | US6987212 from transgenic Exophiala spinifera seeds/plants; for reducing pathogenicity of fumonisin producing fungus to plants |
| 01/17/2006 | US6987171 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 01/17/2006 | US6987169 Nucleotide sequences coding polypeptide for use in the treatment of cancer, heart and viral diseases |
| 01/17/2006 | US6987168 Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites |
| 01/17/2006 | US6987104 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium |
| 01/17/2006 | US6987088 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 01/17/2006 | US6987025 A transgenic plant containing exogenous nucleic acid operably linked to a control element and encoding a polypeptide having an amino acid sequence included in the cytochrome P450 enzyme; synthesis of brassinosteroids; plant growth regulators |
| 01/17/2006 | US6987024 Human ovarian mesothelial cells and methods of isolation and uses thereof |
| 01/17/2006 | US6987023 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use |
| 01/17/2006 | US6987022 Lectin protein derived from Dolichos beans or soybeans; and a physiologically inert carrier material in the form of beads |
| 01/17/2006 | US6987021 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 01/17/2006 | US6987014 Isolated nucleic acid molecules encoding human drug metabolizing proteins |
| 01/17/2006 | US6987013 NADH oxidase from lactobacillus |
| 01/17/2006 | US6987009 αgalactosidases and methods of using them |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6987003 Modulation of RNA transport to the rough endoplasmic reticulum by staufen proteins; isolated nucleic acids encoding this protein and vectors and host cells expressing them; nucleic acid sequences and their encoded amino acid sequences; viricides |
| 01/17/2006 | US6987001 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 01/17/2006 | US6986984 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 01/17/2006 | US6986891 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 01/17/2006 | US6986888 Method for treating mammals with modified mammalian blood |
| 01/17/2006 | US6986887 Universal stem cells |
| 01/17/2006 | US6986881 Identification of compounds that modify transcriptional responses to hypoxia |
| 01/17/2006 | CA2374882C Molecular characterisation of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis |
| 01/17/2006 | CA2309028C The cytoplasmic inhibition of gene expression |
| 01/17/2006 | CA2138382C Alkaline phosphatase enzymes having improved specific activity for use in indicator reagents |
| 01/17/2006 | CA2086425C Fibroblast growth factor receptors |
| 01/12/2006 | WO2006004878A1 Attenuated herpes simplex virus type-2, vectors thereof and immunogenic compositions thereof |
| 01/12/2006 | WO2006004768A2 Immortal cell lines containing non-mitochondrial genetic material within the mitochondria |
| 01/12/2006 | WO2006004728A2 Cell culture medium comprising transition metals or trace elements |
| 01/12/2006 | WO2006004663A2 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 01/12/2006 | WO2006004149A1 Method of producing nerve cell |
| 01/12/2006 | WO2005101014A3 Diagnostic and therapeutic use of kcnc1 for neurodegenerative diseases |
| 01/12/2006 | WO2005047480A3 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast |
| 01/12/2006 | WO2004078130A3 Posh interacting proteins and related methods |
| 01/12/2006 | WO2004071407A3 Antisense modulation of ptp1b expression |
| 01/12/2006 | US20060010530 Soybean cultivar 90046112 |
| 01/12/2006 | US20060010529 Transgenic or hybrid crops has herbicide resistance, insect resistance and disease resistance; cross breeding, genetic engineering, tissue culture |
| 01/12/2006 | US20060010528 Transgenic or hybrid crops has herbicide resistance, insect resistance and disease resistance; cross breeding, genetic engineering, tissue culture |
| 01/12/2006 | US20060010527 Soybean cultivar 03022253 |
| 01/12/2006 | US20060010526 Soybean cultivar 02022433 |
| 01/12/2006 | US20060010525 Soybean cultivar 02022323 |
| 01/12/2006 | US20060010524 Soybean cultivar 02912951 |
| 01/12/2006 | US20060010523 Soybean cultivar 0102115 |
| 01/12/2006 | US20060010522 Hybrid soybean seeds and plants produced by crossing the cultivar 915034 with another soybean cultivar; diseases, insect resistance |
| 01/12/2006 | US20060010518 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 01/12/2006 | US20060010517 Regulation of gene expression in plants |
| 01/12/2006 | US20060010516 Cell cycle genes and related methods |
| 01/12/2006 | US20060010512 Nitrogen transport metabolism |
| 01/12/2006 | US20060010511 Nobel glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthase and gene encoding it |
| 01/12/2006 | US20060010509 Methods and compositions for producing germ cells from bone marrow derived germline stem cells |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009408 siRNA-Mediated gene silencing with viral vectors |
| 01/12/2006 | US20060009406 Vectors having both isoforms of beta-hexosaminidase |
| 01/12/2006 | US20060009402 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 01/12/2006 | US20060009383 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/12/2006 | US20060008908 Method and composition for longevity assurance |
| 01/12/2006 | US20060008906 Electrofusionof cells and apparatus therefore |
| 01/12/2006 | US20060008905 Collagen/glycosaminoglycan compositions for use as terminally sterilizable matrices |
| 01/12/2006 | US20060008904 Cell culture method and apparatus thereof |
| 01/12/2006 | US20060008903 Method and apparatus for collecting cells for macromolecular analysis |
| 01/12/2006 | US20060008902 culturing; cell differentiating into a variety of specific cell types; for diagnostic, drug screening, bone repair, and gene therapeutic applications; homogenous population cells |
| 01/12/2006 | US20060008901 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/12/2006 | US20060008900 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene |
| 01/12/2006 | US20060008889 Phosphatase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, autoimmune, muscular and graft vs. host diseases |
| 01/12/2006 | US20060008882 Antibody or fragment that specifically binds to CK alpha -5 polypeptides; may be chimeric antibody or fragment thereof, a single chain antibody, a Fab fragment, or a F(ab')2 fragment; Western blot or an enzyme-linked immunosorbent assay; hybridoma that produces the antibody |
| 01/12/2006 | US20060008880 Mouse trace amine associated receptors and polypeptides |
| 01/12/2006 | US20060008876 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis |
| 01/12/2006 | US20060008868 Production method of biochemical coal |
| 01/12/2006 | US20060008853 Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the same |
| 01/12/2006 | US20060008816 Promoter, Promoter control elements, and combinations, and uses thereof |
| 01/12/2006 | US20060008797 Peptide that that binds to microglial receptors; may be conjugated to a carrier molecule that increases transport across the blood-brain barrier; treating neurological effects of cerebral ischemia or cerebral inflammation |
| 01/12/2006 | US20060008461 Delivering into phagocytic cells; targeting specific organelles; inhibiting, attenuating, arresting, combating and overcoming microbial infection of phagocytic mammalian cells in vivo and in vitro |